<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=us-ascii"><meta name=Generator content="Microsoft Word 14 (filtered medium)"><!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
        {font-family:Cambria;
        panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
        {font-family:Calibri;
        panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
        {font-family:Tahoma;
        panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
        {font-family:Georgia;
        panose-1:2 4 5 2 5 4 5 2 3 3;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
        {margin:0cm;
        margin-bottom:.0001pt;
        font-size:11.0pt;
        font-family:"Calibri","sans-serif";
        mso-fareast-language:EN-US;}
a:link, span.MsoHyperlink
        {mso-style-priority:99;
        color:blue;
        text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
        {mso-style-priority:99;
        color:purple;
        text-decoration:underline;}
p
        {mso-style-priority:99;
        mso-margin-top-alt:auto;
        margin-right:0cm;
        mso-margin-bottom-alt:auto;
        margin-left:0cm;
        font-size:12.0pt;
        font-family:"Times New Roman","serif";}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
        {mso-style-priority:99;
        mso-style-link:"Balloon Text Char";
        margin:0cm;
        margin-bottom:.0001pt;
        font-size:8.0pt;
        font-family:"Tahoma","sans-serif";
        mso-fareast-language:EN-US;}
span.EmailStyle17
        {mso-style-type:personal-compose;
        font-family:"Cambria","serif";
        color:windowtext;}
span.apple-style-span
        {mso-style-name:apple-style-span;}
span.apple-converted-space
        {mso-style-name:apple-converted-space;}
span.BalloonTextChar
        {mso-style-name:"Balloon Text Char";
        mso-style-priority:99;
        mso-style-link:"Balloon Text";
        font-family:"Tahoma","sans-serif";}
.MsoChpDefault
        {mso-style-type:export-only;
        font-family:"Calibri","sans-serif";
        mso-fareast-language:EN-US;}
@page WordSection1
        {size:612.0pt 792.0pt;
        margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
        {page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=EN-AU link=blue vlink=purple><div class=WordSection1><p style='line-height:14.25pt;background:white'><span style='font-size:10.0pt;font-family:"Georgia","serif";color:black'>This commitment is great news and a wonderful follow-up to the UN global health conference held in Melbourne last month. Here's the media release from GAVI - the Global Alliance for Vaccines and&nbsp;Immunization.<o:p></o:p></span></p><p style='line-height:14.25pt;background:white'><span class=apple-style-span><b><span style='font-size:10.0pt;font-family:"Georgia","serif";color:black'>Mary Robinson, Chair of the GAVI Alliance Board, welcomes the new commitment, which will help save the lives of 4.2 million children</span></b></span><span style='font-size:10.0pt;font-family:"Georgia","serif";color:black'><o:p></o:p></span></p><p style='line-height:14.25pt;background:white'><span class=apple-style-span><span style='font-size:10.0pt;font-family:"Georgia","serif";color:black'>(issued by GAVI)</span></span><b><span style='font-size:10.0pt;font-family:"Georgia","serif";color:black'><br></span></b><b><span style='font-size:10.0pt;font-family:"Georgia","serif";color:black'><img width=1 height=1 id="Picture_x0020_1" src="cid:image001.gif@01CB660B.E04C20B0" alt="Description: http://www.scienceinpublic.com/blog/wp-includes/js/tinymce/plugins/wordpress/img/trans.gif"></span></b><b><span style='font-size:10.0pt;font-family:"Georgia","serif";color:black'><br></span></b><span class=apple-style-span><i><span style='font-size:10.0pt;font-family:"Georgia","serif";color:black'>New York City, 6 October 2010</span></i></span><span class=apple-converted-space><span style='font-size:10.0pt;font-family:"Georgia","serif";color:black'>&nbsp;</span></span><span style='font-size:10.0pt;font-family:"Georgia","serif";color:black'>&#8211; With a new pledge of A$ 60 million (US$ 58 million) over three years, the Government of Australia doubled its previous commitment to the GAVI Alliance on Wednesday and set the pace for other donors at a meeting in New York.<o:p></o:p></span></p><p style='line-height:14.25pt;background:white'><span style='font-size:10.0pt;font-family:"Georgia","serif";color:black'>The meeting of GAVI Alliance partners is part of a process to raise funds for GAVI&#8217;s 2010-2015 programme. If fully funded, GAVI will help developing countries immunise an additional 240 million children and prevent some 4.2 million deaths.<o:p></o:p></span></p><p style='line-height:14.25pt;background:white'><span style='font-size:10.0pt;font-family:"Georgia","serif";color:black'>&#8220;This increase in Australia&#8217;s commitment to support GAVI&#8217;s life-saving work is wonderful news,&#8221; said Mary Robinson, Chair of the GAVI Alliance Board. &#8220;Immunisation is one of the most powerful development interventions that we have,&#8221; she said.<o:p></o:p></span></p><p style='line-height:14.25pt;background:white'><span style='font-size:10.0pt;font-family:"Georgia","serif";color:black'>Australian officials at the meeting said they were delighted to be strengthening their partnership with GAVI because it provides the world&#8217;s poorest countries access to some of the same life-saving vaccines that rich countries have.<o:p></o:p></span></p><p style='line-height:14.25pt;background:white'><span style='font-size:10.0pt;font-family:"Georgia","serif";color:black'>Australia&#8217;s new commitment adds to an existing 20-year commitment for A$ 250 million (US$ 244 million) to the Health Systems Funding Platform, which GAVI has established with other partners.<o:p></o:p></span></p><p style='line-height:14.25pt;background:white'><span style='font-size:10.0pt;font-family:"Georgia","serif";color:black'>GAVI&#8217;s work in the past ten years has seen the immunisation of more than 257 million children and the prevention of 5.4 million premature deaths. On Tuesday, the eve of the one-day meeting, UN Secretary-General Ban Ki-moon endorsed GAVI&#8217;s critical role in improving the lives of poor women and children.<o:p></o:p></span></p><p style='line-height:14.25pt;background:white'><span style='font-size:10.0pt;font-family:"Georgia","serif";color:black'>&#8220;Immunisation &#8211; and all the work of the GAVI Alliance &#8211; is a key part of our strategy,&#8221; he said, referring to the new Global Strategy for Women&#8217;s and Children&#8217;s Health.<o:p></o:p></span></p><p style='line-height:14.25pt;background:white'><span style='font-size:10.0pt;font-family:"Georgia","serif";color:black'>In calculating donor commitments to the G8 Muskoka Initiative, the G8 considers that 100 percent of every dollar contributed to GAVI reaches mothers and children in the developing world.<o:p></o:p></span></p><p style='line-height:14.25pt;background:white'><span style='font-size:10.0pt;font-family:"Georgia","serif";color:black'>GAVI has already raised some US$ 2.7 billion for its ambitious 2010-2015 programme through ground-breaking financing methods, such as the International Finance Facility for Immunisation (IFFIm) but needs an additional US$ 4.3 billion.<o:p></o:p></span></p><p style='line-height:14.25pt;background:white'><span style='font-size:10.0pt;font-family:"Georgia","serif";color:black'>The programme includes the introduction of new vaccines to tackle major causes of the world&#8217;s two biggest childhood killers, pneumonia and diarrhoea -- the leading causes of child mortality, which together account for nearly 40% of all child deaths.<o:p></o:p></span></p><p style='line-height:14.25pt;background:white'><span style='font-size:10.0pt;font-family:"Georgia","serif";color:black'>The programme will also ensure the sustainability of the five-in-one pentavalent vaccine introduced by GAVI to increase basic coverage against diphtheria, tetanus and pertussis (DTP), while also protecting children against Hepatitis B and Hib.<o:p></o:p></span></p><p style='line-height:14.25pt;background:white'><span class=apple-style-span><b><span style='font-size:10.0pt;font-family:"Georgia","serif";color:black'>#&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; #&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; #</span></b></span><span style='font-size:10.0pt;font-family:"Georgia","serif";color:black'><o:p></o:p></span></p><p style='line-height:14.25pt;background:white'><span class=apple-style-span><b><span style='font-size:10.0pt;font-family:"Georgia","serif";color:black'>The GAVI Alliance</span></b></span><span class=apple-converted-space><span style='font-size:10.0pt;font-family:"Georgia","serif";color:black'>&nbsp;</span></span><span style='font-size:10.0pt;font-family:"Georgia","serif";color:black'>is a Geneva-based public-private partnership aimed at improving health in the world&#8217;s poorest countries. The Alliance brings together developing country and donor governments, the World Health Organization, UNICEF, the World Bank, the vaccine industry in both industrialised and developing countries, research and technical agencies, civil society, the Bill &amp; Melinda Gates Foundation and other private philanthropists.<o:p></o:p></span></p><p style='line-height:14.25pt;background:white'><span style='font-size:10.0pt;font-family:"Georgia","serif";color:black'>GAVI support consists of providing life-saving vaccines and strengthening health systems. Since 2000, more than 250 million children have been vaccinated and over five million premature deaths averted thanks to GAVI-funded programmes.<o:p></o:p></span></p><p style='line-height:14.25pt;background:white'><span style='font-size:10.0pt;font-family:"Georgia","serif";color:black'>For more information, please visit:<span class=apple-converted-space>&nbsp;</span><a href="http://www.gavialliance.org/"><span class=apple-style-span><b><span style='color:blue;text-decoration:none'>www.gavialliance.org</span></b></span></a><o:p></o:p></span></p><p style='line-height:14.25pt;background:white'><span class=apple-style-span><b><span style='font-size:10.0pt;font-family:"Georgia","serif";color:black'>Media requests:</span></b></span><span style='font-size:10.0pt;font-family:"Georgia","serif";color:black'><o:p></o:p></span></p><p style='line-height:14.25pt;background:white'><span style='font-size:10.0pt;font-family:"Georgia","serif";color:black'><a href="mailto:jrowland@gavialliance.org"><span class=apple-style-span><b><span style='color:blue;text-decoration:none'>Claire McGeehan</span></b></span></a><span class=apple-converted-space>&nbsp;</span>&#8211; AusAID, Camberra<o:p></o:p></span></p><p style='line-height:14.25pt;background:white'><span style='font-size:10.0pt;font-family:"Georgia","serif";color:black'>Mobile: +404 479 226<o:p></o:p></span></p><p style='line-height:14.25pt;background:white'><span style='font-size:10.0pt;font-family:"Georgia","serif";color:black'><a href="mailto:Claire.McGeechan@ausaid.gov.au"><span class=apple-style-span><b><span style='color:blue;text-decoration:none'>Claire.McGeechan@ausaid.gov.au</span></b></span></a><o:p></o:p></span></p><p style='line-height:14.25pt;background:white'><span class=apple-style-span><i><span style='font-size:10.0pt;font-family:"Georgia","serif";color:black'>Note: Science in Public has helped GAVI in the past but we weren't involved in this announcement.</span></i></span><span style='font-size:10.0pt;font-family:"Georgia","serif";color:black'><o:p></o:p></span></p><p class=MsoNormal><span style='font-family:"Cambria","serif"'><o:p>&nbsp;</o:p></span></p><p class=MsoNormal><span style='font-family:"Cambria","serif"'><o:p>&nbsp;</o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-family:"Cambria","serif";mso-fareast-language:EN-AU'>________<o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-family:"Cambria","serif";mso-fareast-language:EN-AU'><o:p>&nbsp;</o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-family:"Cambria","serif";mso-fareast-language:EN-AU'>Niall Byrne<o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-family:"Cambria","serif";mso-fareast-language:EN-AU'><o:p>&nbsp;</o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-family:"Cambria","serif";mso-fareast-language:EN-AU'>Science in Public<o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-family:"Cambria","serif";mso-fareast-language:EN-AU'>26 Railway Street South, Altona Vic 3018<o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-family:"Cambria","serif";mso-fareast-language:EN-AU'>ph +61 (3) 9398 1416 or 0417 131 977<o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-family:"Cambria","serif";mso-fareast-language:EN-AU'><a href="mailto:niall@scienceinpublic.com.au"><span style='color:blue'>niall@scienceinpublic.com.au</span></a><o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-family:"Cambria","serif";mso-fareast-language:EN-AU'>Twitter scienceinpublic<o:p></o:p></span></p><p class=MsoNormal><span lang=EN-US style='font-family:"Cambria","serif";mso-fareast-language:EN-AU'>Full contact details at <a href="http://www.scienceinpublic.com.au/blog"><span style='color:blue'>www.scienceinpublic.com.au/blog</span></a>&nbsp; <o:p></o:p></span></p><p class=MsoNormal><o:p>&nbsp;</o:p></p></div></body></html>